Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$2.13 - $3.84 $21,300 - $38,400
10,000 New
10,000 $23,000
Q4 2022

Jan 10, 2023

BUY
$4.56 - $6.61 $22,799 - $33,050
5,000 Added 50.0%
15,000 $0
Q3 2022

Oct 13, 2022

BUY
$3.75 - $6.63 $37,500 - $66,300
10,000 New
10,000 $62,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $335M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Ewg Elevate Inc. Portfolio

Follow Ewg Elevate Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewg Elevate Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ewg Elevate Inc. with notifications on news.